Rockefeller Capital Management L.P. Instil Bio, Inc. Transaction History

Rockefeller Capital Management L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 17, 2023	SELL	$0.6 - $0.91 $1,020 - $1,547	-1,700 Reduced 2.23%	74,600 $49,000
Q4 2022 Mar 06, 2023	BUY	$0.48 - $5.33 $21,690 - $240,852	45,188 Added 145.24%	76,300 $48,000
Q3 2022 Nov 02, 2022	BUY	$4.65 - $7.37 $59,603 - $94,468	12,818 Added 70.07%	31,112 $150,000
Q2 2022 Aug 12, 2022	BUY	$4.21 - $11.15 $69,860 - $185,023	16,594 Added 976.12%	18,294 $83,000
Q2 2021 Aug 10, 2021	BUY	$15.31 - $24.63 $26,027 - $41,871	1,700 New	1,700 $32,000

1.9M

Ticker TIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,694,000
Market Cap $2.67B
Description
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.